Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

NCT01009801 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped due to slow patient recruitement.

Conditions

Liver Cancer

Interventions

DRUG: doxorubicin-eluting beads
DRUG: everolimus
OTHER: placebo

Sponsor

Swiss Cancer Institute